The Medlab Middle East exhibition in Dubai is the largest and most influential medical laboratory equipment and supplies exhibition in the Middle East region. Every year, medical enterprises, scientific research institutions, and industry experts from around the world gather here to showcase the latest scientific research achievements, cutting - edge technologies, and innovative products, and jointly discuss the development trends of the industry. As a leading company in the domestic in - vitro diagnostic field, Genrui Biotech demonstrating its outstanding elegance on the international stage.
At this exhibition, Genrui Biotech attracted the attention of numerous visitors with its unique booth design and rich display content. Genrui Biotech showcased a series of advanced diagnostic equipment developed independently, including the innovative fully-auto specific protein system PA240&PA480, the POCT hematology analyzer KT- 20, the fully-auto 5-part hematology analyzer KT-8000, the 12-channel immunofluorescence system FA30, and the fully-auto chemiluminescence immunoassay system MT60, etc. These products won high praise from the professionals on-site.
Genrui International Team at Dubai World Trade Centre, Booth Z4.C49.
Specific Protein series
PA240&PA480 – Fully-auto Specific Protein analyzer
PA240 and PA480 are two fully automatic specific protein analyzers, using advanced nephelometry, which greatly improves the sensitivity and specificity of detection, and makes the test menu more comprehensive, including kidney function items, rheumatism immunity, inflammation, blood glucose detection, etc., while colorimetry method supports a variety of biochemistry items, which can provide a complete kidney disease solution to meet the testing needs of different scenarios.
Hematology series
KT-20- POCT Hematology Analyzer
KT-20 is a brand new fully automated POCT hematology analyzer. With simple operation, fast and lab-quality result, KT-20 can simultaneously access to CBC, CRP and SAA test result for patient early infection screening and monitoring. Single use cartridge can save working cost for end users. Built-in battery can support emergency and recycle use. Compact and user-friendly design can realize pleasant testing experience.
Immunofluorescence series
FA30 -- Quantitative Immunoassay Analyzer
The FA30 is a high-performance, 12-channel immunofluorescence analyzer designed for medium-sized laboratories. With the capability to simultaneously test up to 12 different items, it significantly enhances testing efficiency. Each channel is equipped with an independent temperature control system, ensuring accuracy and consistency in results. FA30 is ideal for laboratories processing around 30 samples per day, helping to increase productivity while maintaining reliable and precise results.
Chemiluminescence series
MT60-- Fully-auto Chemiluminescence Immunoassay System
The MT60 is a fully-auto chemiluminescence immunoassay system. It uses enzyme - catalyzed chemiluminescence detection, ensuring accurate results. With a testing speed of 60 tests per hour, it can meet the testing needs of small and medium-sized laboratories. The analyzer adopts small-package reagents to avoid waste. Moreover, it supports whole-blood testing and features easy operation.
The journey of the Medlab Middle East exhibition in Dubai has successfully come to an end. Through this exhibition platform, Genrui Biotech has demonstrated to the world the innovative strength and development potential of Chinese in-vitro diagnostic enterprises, enhancing the brand's international visibility and influence. At the same time, it has laid a solid foundation for Genrui Biotech to expand into international markets and strengthen international cooperation.
In the future, armed with the valuable experience and cooperation opportunities gained from this exhibition, Genrui Biotech will continue to deeply explore the international market, contributing to global healthcare with innovative technologies. We look forward to your continuous attention to Genrui Biotech. Let's witness more glorious moments of the company on the international stage together and jointly create a bright future for the medical industry.
